Last updated 6 months ago

PTCy and ATG for MSD and MUD Transplants

50 patients around the world

Available in Brazil

Instituto Nacional de Cancer, Brazil

1Research sites

50Patients around the world

This study is for people with

Leukemia

Acute lymphoblastic leukemia

Myelodysplastic Syndromes

Acute myeloid leukemia

Non-Hodgkin Lymphoma

Lymphoma

Hodgkin lymphoma

Graft versus Host Disease

To 60 Years

All Gender

: Patient with acute leukemia in first or second remission.
Patient with myelodysplasia with less than 20% blasts.
Patient with Hodgkin's or non-Hodgkin's lymphoma, in partial remission after salvage therapy.
Who will receive a related or unrelated, HLA-compatible transplant.
Who is a transplant candidate with FluMel, FluTBI, CyTBI, BuCy or BuFlu conditioning.
Peripheral blood source.
Age between 18 and 60 years.

: Renal dysfunction (Cr > 1.5 mg/dL)
Hepatic dysfunction (transaminases x2 the normal value)

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA

Recruiting

Pr. da Cruz Vermelha, 23 - Centro, Rio de Janeiro - RJ, 20230-130

SponsorInstituto Nacional de Cancer, Brazil

Conditions

Acute lymphoblastic leukemiaMyelodysplastic SyndromesAcute myeloid leukemiaNon-Hodgkin LymphomaHodgkin lymphomaGraft versus Host Disease

Requirements

To 60 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT06299462